Wordt geladen...
HER2 expression in cervical cancer as a potential therapeutic target
BACKGROUND: Trastuzumab, a humanized monoclonal antibody against the HER2 receptor is currently being used in breast and other tumor types. Early studies have shown that a variable proportion of cervical carcinoma tumors overexpress the HER2 receptor as evaluated by diverse techniques and antibodies...
Bewaard in:
| Hoofdauteurs: | , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2004
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC517717/ https://ncbi.nlm.nih.gov/pubmed/15341668 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-4-59 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|